Trial intelligence / Profile preview

Ultrasound Contrast Agent (Perflubutane) to Enhance Cell-free DNA Detection in Pancreatic Cancer Surgery Candidates

jRCTs071240095Recruiting

Start
Jan 2025
Modality
Acoustic/Optical: Sonoporation, laser photoporation → Physical Methods → Gene Addition/Replacement → Gene Therapies, Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Open-label, single-arm trial of sonazoid in pancreatic adenocarcinoma (PDAC). Started Jan 2025; status: recruiting.

02

Drugs

sonazoid
03

Conditions

pancreatic adenocarcinoma (PDAC)

Beyond the preview

Go deeper on jRCTs071240095.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs071240095.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call